These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2243358)

  • 1. Levodopa delivery from controlled-release polymer matrix: delivery of more than 600 days in vitro and 225 days of elevated plasma levels after subcutaneous implantation in rats.
    Sabel BA; Dominiak P; Häuser W; During MJ; Freese A
    J Pharmacol Exp Ther; 1990 Nov; 255(2):914-22. PubMed ID: 2243358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended levodopa release from a subcutaneously implanted polymer matrix in rats.
    Sabel BA; Dominiak P; Hüaser W; During MJ; Freese A
    Ann Neurol; 1990 Nov; 28(5):714-7. PubMed ID: 2260860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectiveness of slow release L-DOPA/benserazide in treatment of end-of-dose akinesia in Parkinson disease].
    Eichhorn TE; Schrag A; Trenkwalder C; Selzer R; Kohnen R; Oertel WH; Poewe W
    Nervenarzt; 1995 Dec; 66(12):933-41. PubMed ID: 8584079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Slow-release L-dopa vs. standard L-dopa in Parkinson patients in various stages of the disease. Studies of pharmacokinetics and motor effectiveness].
    Bergemann N; Baas H; Fischer PA
    Nervenarzt; 1994 Apr; 65(4):250-7. PubMed ID: 8015632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery.
    Reza MS; Quadir MA; Haider SS
    J Pharm Pharm Sci; 2003; 6(2):282-91. PubMed ID: 12935440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodegradable polymer-mediated intratumoral delivery of cisplatin for treatment of human head and neck squamous cell carcinoma in a chimeric mouse model.
    Chen FA; Kuriakose MA; Zhou MX; DeLacure MD; Dunn RL
    Head Neck; 2003 Jul; 25(7):554-60. PubMed ID: 12808659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pulmonary formulation of L-dopa enhances its effectiveness in a rat model of Parkinson's disease.
    Bartus RT; Emerich D; Snodgrass-Belt P; Fu K; Salzberg-Brenhouse H; Lafreniere D; Novak L; Lo ES; Cooper T; Basile AS
    J Pharmacol Exp Ther; 2004 Aug; 310(2):828-35. PubMed ID: 15039453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A new levodopa benserazide preparation for Parkinson's disease with motor fluctuations refractory to standard L-dopa].
    Fernández Pardal MM; Gatto E; Micheli F; Casas Parera I; Diaz S
    Medicina (B Aires); 1991; 51(6):561-7. PubMed ID: 7476112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled diffusional release of dispersed solute drugs from biodegradable implants of various geometries.
    Collins R; Paul Z; Reynolds DB; Short RF; Wasuwanich S
    Biomed Sci Instrum; 1997; 33():137-42. PubMed ID: 9731349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-dopa treatment and Parkinson's disease.
    Lees AJ
    Q J Med; 1986 Jun; 59(230):535-47. PubMed ID: 3529159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Parkinson's disease: levodopa as the first choice.
    Katzenschlager R; Lees AJ
    J Neurol; 2002 Sep; 249 Suppl 2():II19-24. PubMed ID: 12375059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of carbidopa on plasma and muscle levels of L-dopa, dopamine, and their metabolites following L-dopa administration to rats.
    Rose S; Jenner P; Marsden CD
    Mov Disord; 1988; 3(2):117-25. PubMed ID: 3221899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of controlled release of DOPA and carbidopa on clinical response and plasma pharmacokinetics of DOPA in parkinsonian patients].
    García de Yébenes J; Mateo D; Pino MA; Cordero M; Pastor M; Chacón J; Morales B; Sánchez V; Mena MA; Giménez Roldán S
    Neurologia; 1997 Apr; 12(4):145-56. PubMed ID: 9235023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic evaluation and modeling of formulated levodopa intranasal delivery systems.
    Kim TK; Kang W; Chun IK; Oh SY; Lee YH; Gwak HS
    Eur J Pharm Sci; 2009 Dec; 38(5):525-32. PubMed ID: 19804823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.
    Henry B; Crossman AR; Brotchie JM
    Exp Neurol; 1999 Feb; 155(2):204-20. PubMed ID: 10072296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The "motor complication syndrome" in rats with 6-OHDA lesions treated chronically with L-DOPA: relation to dose and route of administration.
    Lindgren HS; Rylander D; Ohlin KE; Lundblad M; Cenci MA
    Behav Brain Res; 2007 Feb; 177(1):150-9. PubMed ID: 17157933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo characterization of a novel biocompatible polymer-lipid implant system for the sustained delivery of paclitaxel.
    Ho EA; Vassileva V; Allen C; Piquette-Miller M
    J Control Release; 2005 May; 104(1):181-91. PubMed ID: 15866344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of cisapride on plasma L-dopa levels and clinical response in Parkinson's disease.
    Neira WD; Sanchez V; Mena MA; de Yebenes JG
    Mov Disord; 1995 Jan; 10(1):66-70. PubMed ID: 7885357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of acute ethanol administration on brain levels of tetrahydropapaveroline in L-dopa-treated rats.
    Cashaw JL; Geraghty CA; McLaughlin BR; Davis VE
    J Neurosci Res; 1987; 18(3):497-503. PubMed ID: 3125342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonergic activation after 2-week intrastriatal infusion of L-dopa and slow recovery of circling in rats with unilateral nigral lesions.
    Kääriäinen TM; García-Horsman JA; Piltonen M; Huotari M; Männistö PT
    Basic Clin Pharmacol Toxicol; 2008 Mar; 102(3):300-7. PubMed ID: 17973898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.